Form 8-K - Current report:
SEC Accession No. 0001193125-25-257435
Filing Date
2025-10-30
Accepted
2025-10-30 07:39:59
Documents
16
Period of Report
2025-10-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d54035d8k.htm   iXBRL 8-K 53219
2 EX-99.1 d54035dex991.htm EX-99.1 17043
3 EX-99.2 d54035dex992.htm EX-99.2 630533
4 EX-99.3 d54035dex993.htm EX-99.3 53764
5 EX-99.4 d54035dex994.htm EX-99.4 144618
  Complete submission text file 0001193125-25-257435.txt   1243249

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mtsr-20251029.xsd EX-101.SCH 2837
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtsr-20251029_lab.xml EX-101.LAB 18736
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtsr-20251029_pre.xml EX-101.PRE 11698
18 EXTRACTED XBRL INSTANCE DOCUMENT d54035d8k_htm.xml XML 3769
Mailing Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007
Business Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007 (212) 784-6595
Metsera, Inc. (Filer) CIK: 0002040807 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42489 | Film No.: 251432245
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)